Page last updated: 2024-09-04

xamoterol and pimobendan

xamoterol has been researched along with pimobendan in 4 studies

Compound Research Comparison

Studies (xamoterol)	Trials (xamoterol)	Recent Studies (post-2010) (xamoterol)	Studies (pimobendan)	Trials (pimobendan)	Recent Studies (post-2010) (pimobendan)
269	80	17	348	67	101

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erhardt, PW	1
Lombardo, F; Obach, RS; Waters, NJ	1
Hasenfuss, G; Holubarsch, CH; Just, HJ; Thierfelder, L	1
Chiotti, D; Presbitero, P	1

Reviews

2 review(s) available for xamoterol and pimobendan

Article	Year
In search of the digitalis replacement. Journal of medicinal chemistry, 1987, Volume: 30, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship	1987
[New inotropic drugs]. Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:8 Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol	1988

Other Studies

2 other study(ies) available for xamoterol and pimobendan

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Myocardial energetics in dilated cardiomyopathy. Clinical cardiology, 1990, Volume: 13, Issue:9 Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol	1990

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Myocardial energetics in dilated cardiomyopathy.

Clinical cardiology, 1990, Volume: 13, Issue:9

Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol

1990